跳至主要内容
临床试验/IRCT2014061118061N1
IRCT2014061118061N1已完成未知

A therapeutic and side effects comparison between Rosastim and Brand type (Neupogen) in gastric cancer

Behin Tamin Rosamed Co.0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • inclusion criteria: 1.Patients with gastric cancers, age 18-65, both sex 2.Biopsy and pathology results 3.Filling the consent form through patients or guardian 4.Possible cooperation of patients till the study completed.
  • exclusion criteria: 1.Ill-informed patient consent for participation in the study 2.Initial CBC disruption, so that lead to the wrong result in lab tests 3.Hypersensitivity to one type of Granolocyte Colony Stimulating Factor 4.History of treated malignancy or co-current malignancy 5.patient may require radiation during treatment 6.recurrent gastric cancer or refractory one that have previously been treated 7.Inappropriate performance status for start or continue treatment 8.Mental illness or depression such that the compliance reduce.

排除标准

  • 未提供

研究者

发起方
Behin Tamin Rosamed Co.

相似试验